End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
01:30pm | Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 20 | Tenax Therapeutics Secures Global Rights for Levosimendan | MT |
- Stock
- Equities
- Stock Tenax Therapeutics, Inc.
- Stock Oxygen Biotherapeutics Inc - Nasdaq
- News Oxygen Biotherapeutics Inc